News and Events
SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools
SUMMIT is in its 6th and final year and most of the goals we set out to accomplish have by now been reached, creating a wealth of data and results on markers for Diabetes complications.
Follow the links below for more detail on our major achievements.
Summary of major achievements for SUMMIT, year 5
Summary of major achievements for SUMMIT, year 4
Summary of major achievements for SUMMIT, year 3
To DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:
the identification of patients at high risk of diabetes complications
the monitoring of the complications' progression and patients‘ response to therapy
To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.
Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.